What is Strobilanthes cusia used for in traditional medicine?

In traditional Chinese medicine, the aerial parts of Strobilanthes cusia are processed into Qing-Dai and used for heat-clearing, detoxification, and anti-inflammatory conditions including febrile infections, throat inflammation, and skin eruptions, while the roots (Nan-Ban-Lan-Gen) are used for antiviral and immunomodulatory purposes. In Vietnamese traditional medicine, the plant is specifically valued as an antiviral agent for febrile and epidemic illnesses. Both applications are documented in official pharmacopoeias and supported by phytochemical evidence of biologically active indole alkaloids.

What is indirubin and why is it important in Strobilanthes cusia?

Indirubin is an indole alkaloid and the primary pharmacologically active compound in Strobilanthes cusia, responsible for much of the plant's antitumor and anti-inflammatory activity. It inhibits cyclin-dependent kinase 1 (CDK1) in complex with cyclin B at an IC₅₀ of 10 μM in vitro, arresting cell cycle progression at the G2/M checkpoint, and also inhibits glycogen synthase kinase-3 beta (GSK-3β), modulating Wnt/β-catenin signaling. Indirubin derivatives have been clinically investigated in China for chronic myeloid leukemia, establishing it as one of the most clinically relevant natural CDK inhibitors.

Is Strobilanthes cusia safe to take as a supplement?

The comprehensive safety profile of Strobilanthes cusia has not been established through formal human clinical trials, and several cautions apply. Qing-Dai preparations containing indigo from this and related plants have been linked to pulmonary arterial hypertension in case reports, particularly with long-term oral use, and the constituent 4(3H)-quinazolinone has hypotensive activity that may interact with antihypertensive drugs. Use during pregnancy or breastfeeding is not recommended, and individuals taking chemotherapy agents, immunosuppressants, or blood pressure medications should seek medical advice before supplementation.

What is the difference between Qing-Dai and Nan-Ban-Lan-Gen?

Both Qing-Dai and Nan-Ban-Lan-Gen are derived from Strobilanthes cusia but represent different plant parts and preparations with distinct traditional indications. Qing-Dai refers to the processed aerial parts (leaves and stems) dried and used as a blue-green powder or paste, rich in indigo, indirubin, and tryptanthrin, used primarily for anti-inflammatory and antitumor purposes including skin conditions. Nan-Ban-Lan-Gen refers to the processed roots of the plant, used more specifically for antiviral and throat-related indications in traditional Chinese medicine, and both are listed as official drugs in the Chinese Pharmacopoeia.

What does the current research say about Strobilanthes cusia for cancer?

Current research on S. cusia and cancer is limited to in vitro cell culture studies and preclinical phytochemical analyses, with no direct human clinical trials on the whole plant for oncology indications. In laboratory settings, indirubin inhibits CDK1-cyclin B at 10 μM IC₅₀, induces apoptosis via Bax/caspase-3 upregulation and Bcl-2 downregulation, and has shown potential to reverse multidrug resistance in cancer cell models. While indirubin synthetic derivatives have been studied clinically in China for leukemia, the evidence is insufficient to recommend S. cusia extracts as a cancer treatment, and further rigorous human trials are needed to translate preclinical findings into validated clinical outcomes.

Does Strobilanthes cusia interact with antiviral medications or antiretroviral drugs?

While Strobilanthes cusia contains alkaloids like tryptanthrin and indirubin with antiviral properties, there is limited clinical data on interactions with prescription antivirals or antiretrovirals. Because both the herb and certain antiviral medications may affect viral replication pathways, concurrent use should be discussed with a healthcare provider to avoid potential synergistic or antagonistic effects. More research is needed to establish safe co-administration guidelines.

What is the most effective form of Strobilanthes cusia—fresh, dried, extract, or powder?

Traditional preparation methods vary between regions: Qing-Dai (the dried, powdered leaf used in Chinese medicine) and Nan-Ban-Lan-Gen (the root used in Vietnamese tradition) represent different bioactive profiles, with indirubin concentrations potentially varying by plant part and drying method. Standardized extracts targeting indirubin content may offer more consistent dosing than raw plant material, though absorption rates differ depending on whether the product is taken as a decoction, powder, or concentrated extract. Clinical evidence comparing forms directly is limited, making traditional preparation methods a reasonable reference point for supplementation.

Who should avoid Strobilanthes cusia supplementation due to existing health conditions?

Individuals with bleeding disorders or taking anticoagulant medications should exercise caution, as indirubin and related alkaloids may influence clotting pathways. People with hormone-sensitive cancers should consult a healthcare provider before use, given indirubin's antiproliferative effects on certain cell lines. Those with liver or kidney impairment should also seek professional guidance, as the organ systems metabolize and eliminate the herb's active compounds.

Strobilanthes cusia

Strobilanthes cusia contains indole alkaloids — primarily indirubin, indigo, and tryptanthrin — that exert antiviral, anti-inflammatory, and antitumor effects through inhibition of cyclin-dependent kinase 1 (CDK1)-cyclin B complexes and modulation of apoptotic pathways. Indirubin, the most pharmacologically characterized compound, demonstrates CDK1-cyclin B inhibitory activity at an IC₅₀ of 10 μM in vitro, positioning it as a candidate for cell cycle arrest in proliferative diseases, though human clinical trial data remain limited.

Category: Southeast Asian Evidence: 1/10 Tier: Preliminary

Strobilanthes cusia — Hermetica Encyclopedia

Origin & History

Strobilanthes cusia is native to tropical and subtropical Asia, including southern China, Vietnam, India, Myanmar, and parts of Southeast Asia, where it thrives in moist, shaded forest understories and humid highland regions. It has been cultivated for centuries across these regions both as a medicinal plant and as a natural dye source, particularly in Yunnan province of China and northern Vietnam. The plant is a perennial herb in the Acanthaceae family that favors well-drained, humus-rich soils at moderate elevations and is harvested during late summer and autumn for medicinal processing.

Historical & Cultural Context

Strobilanthes cusia has a documented history spanning over a millennium in traditional Chinese medicine, where its aerial parts processed into Qing-Dai (natural indigo) and its roots designated as Nan-Ban-Lan-Gen are both recorded in the Chinese Pharmacopoeia as official materia medica for heat-clearing, detoxifying, and anti-inflammatory indications. In Vietnamese traditional medicine, the plant occupies a prominent position as an antiviral and febrifuge, used in preparations to treat epidemic febrile illnesses including those with suspected viral etiology, reflecting its widespread geographic distribution across mainland Southeast Asia. The plant also holds significant cultural importance as a natural blue dye across Asia; indigenous communities in Yunnan, Assam, and northern Vietnam have used fermented leaf extracts to produce a deep blue indigo dye for textiles, a practice that has co-existed with its medicinal applications for centuries. Historical Chinese materia medica texts including the Bencao Gangmu reference indigo-containing preparations for throat infections, skin eruptions, and high fevers, establishing a rich ethnopharmacological basis that has guided modern phytochemical investigation.

Health Benefits

- **Antiviral Activity**: The aerial parts and roots of S. cusia, used as Qing-Dai and Nan-Ban-Lan-Gen in Chinese medicine respectively, have demonstrated antiviral properties in traditional Vietnamese and Chinese contexts, with alkaloids such as tryptanthrin and indirubin implicated in disrupting viral replication pathways.
- **Antitumor and Antiproliferative Effects**: Indirubin inhibits CDK1-cyclin B at an IC₅₀ of 10 μM in vitro, inducing cell cycle arrest at the G2/M checkpoint and triggering apoptosis in cancer cell lines, making it one of the most studied anticancer compounds derived from traditional Chinese medicine indigo plants.
- **Anti-inflammatory Properties**: Tryptanthrin and indirubin suppress pro-inflammatory cytokine production and modulate NF-κB signaling, contributing to the plant's traditional use for inflammatory skin conditions and febrile illness.
- **Antioxidant Capacity**: S. cusia extracts exhibit significant total phenolic content (approximately 104.41 mg GAE/g crude extract), which correlates with free radical scavenging activity that may protect cells from oxidative stress-mediated damage.
- **Hepatoprotective Effects**: Preclinical evidence suggests that bioactive compounds in S. cusia exert liver-protective actions, potentially through antioxidant mechanisms and suppression of hepatic inflammatory cascades, consistent with its traditional use in treating liver-related conditions.
- **Neuroprotective Potential**: Emerging preclinical data indicate that indole alkaloids from S. cusia may protect neuronal cells from oxidative and inflammatory insults, though this area of research remains at an early stage without human trial validation.
- **Multidrug Resistance Reversal**: Laboratory studies suggest that indirubin and related compounds can sensitize cancer cells to conventional chemotherapeutic agents by overcoming P-glycoprotein-mediated efflux mechanisms, representing a potential adjunctive oncology application.

How It Works

The primary molecular mechanism of S. cusia's bioactive indole alkaloids centers on indirubin's competitive inhibition of cyclin-dependent kinase 1 (CDK1) in complex with cyclin B, with an IC₅₀ of 10 μM, which arrests the cell cycle at the G2/M transition and prevents aberrant cell proliferation. Indirubin also inhibits glycogen synthase kinase-3 beta (GSK-3β), modulating downstream Wnt/β-catenin signaling and contributing to both antiproliferative and neuroprotective effects. Tryptanthrin, a quinazoline-fused indole compound, suppresses cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression via NF-κB pathway inhibition, thereby reducing prostaglandin E2 and nitric oxide-mediated inflammation. Collectively, these compounds also upregulate pro-apoptotic proteins such as Bax and caspase-3 while downregulating anti-apoptotic Bcl-2 expression, facilitating programmed cell death in tumor cell models.

Scientific Research

The body of evidence for S. cusia is predominantly preclinical, consisting of in vitro phytochemical characterization studies, cell-line cytotoxicity assays, and animal model experiments, with no robust human randomized controlled trials specifically on this species identified in the current literature. Phytochemical analyses have comprehensively identified over 209 chemical constituents including indole alkaloids, triterpenes, quinazolinones, flavonoids, and phenolics, providing a strong chemical foundation for further pharmacological investigation. Cytotoxicity studies using related Strobilanthes species have demonstrated IC₅₀ values against hepatocellular carcinoma cell lines (HepG-2) in the range of 38.8 µg/mL, numerically comparable to the chemotherapeutic agent 5-fluorouracil (IC₅₀ 37.3 µg/mL), but these are in vitro data that cannot be extrapolated directly to clinical efficacy or safety in humans. The documented use of indirubin derivatives in Chinese clinical oncology practice provides indirect clinical relevance, but rigorously designed trials specifically attributing outcomes to S. cusia as a whole plant preparation remain absent from the published literature.

Clinical Summary

No large-scale randomized controlled trials have been conducted specifically using Strobilanthes cusia as a standardized intervention in human subjects, representing a significant evidence gap for this traditionally important plant. The clinical use of its primary bioactive, indirubin, has been explored in chronic myeloid leukemia (CML) studies using synthetic derivatives, providing proof-of-concept for CDK inhibition as a therapeutic mechanism, but these trials do not directly assess the whole herb or crude extract. Traditional clinical application in Vietnamese and Chinese medicine — particularly in febrile viral illnesses, inflammatory skin conditions, and cancer supportive care — has occurred over centuries, but systematic outcome measurement has not been formalized in peer-reviewed trial formats. Confidence in specific effect sizes for S. cusia as an isolated ingredient remains low, and current evidence does not support definitive clinical recommendations pending well-designed human trials.

Nutritional Profile

Strobilanthes cusia is not consumed as a dietary food ingredient and does not contribute meaningful macronutrients (carbohydrates, proteins, or fats) in therapeutic dosages. Its pharmacologically relevant profile is dominated by indole alkaloids: indirubin and indigo (present at approximately 0.0622 mg/g crude extract) and tryptanthrin (approximately 0.1138 mg/g crude extract) as determined by HPLC in microwave-assisted aqueous extracts. Total phenolic content is substantial at approximately 104.41 mg gallic acid equivalents (GAE) per gram of crude extract, indicating a rich pool of antioxidant phenolic compounds including flavonoids. Additional phytochemicals include triterpenes (lupeol, betulin, lupenone), quinazolinone alkaloids (4(3H)-quinazolinone and 2,4(1H,3H)-quinazolinedione), phytosterols, and volatile terpenoid compounds among a total of over 209 identified chemical constituents; bioavailability data for these compounds in human pharmacokinetic studies are currently lacking.

Preparation & Dosage

- **Qing-Dai (dried powder of aerial parts)**: Used in traditional Chinese medicine at 1.5–3 g per day as a crude powder, typically administered in capsules or mixed with other herbal preparations; standardization to indirubin content is recommended but not universally established.
- **Nan-Ban-Lan-Gen (processed root decoction)**: Traditionally prepared as a water decoction using 9–15 g of dried root boiled in 300–500 mL water for 20–30 minutes, consumed as a tea for antiviral and anti-inflammatory indications.
- **Ethanol or Hydroethanolic Extract**: Research preparations use 50% ethanol microwave-assisted extraction, yielding standardized concentrations of tryptanthrin (~0.1138 mg/g) and indigo (~0.0622 mg/g); no universally accepted commercial supplement dosage is established.
- **Solvent-Free Microwave-Assisted Extract (MAE)**: Used in research settings with distilled water as solvent, yielding total phenolic content of approximately 104.41 mg GAE/g crude extract; optimal for preserving phenolic antioxidant fractions.
- **Topical Paste (Indigo Naturalis/Qing-Dai)**: For inflammatory skin conditions such as plaque psoriasis, topical preparations of Qing-Dai (which includes S. cusia-derived indigo) have been used at concentrations of 5–10% in ointment bases; clinical trials on Qing-Dai for psoriasis have used 5% topical formulations.
- **Timing Note**: Traditional oral preparations are generally taken on an empty stomach or between meals to optimize gastrointestinal absorption of alkaloids; specific pharmacokinetic timing data for S. cusia isolates are not established in humans.

Synergy & Pairings

Indirubin from S. cusia has demonstrated mechanistic complementarity with other CDK inhibitors and anti-inflammatory botanicals; co-administration with berberine (from Berberis species) has been explored in preclinical models for enhanced apoptotic signaling through parallel NF-κB and CDK pathway inhibition. In traditional Chinese medicine, S. cusia is frequently combined with Isatis tinctoria (Ban-Lan-Gen) and Lonicera japonica (Jin Yin Hua) in antiviral formulations, with the hypothesis that overlapping but distinct antiviral and anti-inflammatory mechanisms provide broader-spectrum activity than any single herb alone. Tryptanthrin's anti-inflammatory activity may be potentiated by quercetin and other flavonoids that similarly suppress COX-2 and iNOS, supporting combination with flavonoid-rich botanicals such as elderberry or green tea extract in anti-inflammatory stacks.

Safety & Interactions

The safety profile of Strobilanthes cusia has not been comprehensively established through formal toxicological studies or large-scale human safety trials, and caution is warranted when extrapolating from traditional use patterns to supplemental contexts. One identified constituent, 4(3H)-quinazolinone (compound VI), has documented hypotensive activity, which raises the potential for additive blood pressure-lowering effects when co-administered with antihypertensive medications such as ACE inhibitors, beta-blockers, or calcium channel blockers. Indigo-containing preparations (Qing-Dai) have been associated with pulmonary arterial hypertension in case reports from Japan, particularly with prolonged oral use for ulcerative colitis, which represents a serious potential adverse event that warrants monitoring. Pregnancy and lactation safety data are absent for this specific species; given the presence of pharmacologically active alkaloids capable of modulating cell proliferation and cytokine expression, use during pregnancy or breastfeeding is not recommended without medical supervision, and individuals on chemotherapy, immunosuppressants, or anticoagulants should consult a healthcare provider before use.